Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-064457
Filing Date
2024-03-11
Accepted
2024-03-11 09:46:56
Documents
1
Effectiveness Date
2024-03-11

Document Format Files

Seq Description Document Type Size
1 S-8 POS d763376ds8pos.htm S-8 POS 25881
  Complete submission text file 0001193125-24-064457.txt   26974
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-229592 | Film No.: 24736812
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)